Factors influencing patient satisfaction after treatments for early-stage non-small cell lung cancer

Pompili, Cecilia; Dalmia, Sanjush; Battleday, Finn McLennan; Rogers, Zoe; Absolom, Kate; Bekker, Hilary; Franks, K.; Brunelli, Alessandro; Velikova, Galina

doi:10.1007/s00432-021-03795-0

Cited by 8 publications

(2 citation statements)

References 19 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In line with the observed high compliance rates for app-based ePRO monitoring, patient satisfaction was high, and several domains of satisfaction were significantly improved by digital monitoring compared to standard-of-care monitoring. Overall, patient satisfaction values, as assessed by the PSQ-18 questionnaire, were comparable to those observed in other trial data sets [27,28]. To the best of our knowledge, no previous trials have investigated patient satisfaction with telemonitoring during radiotherapy based on standardized and validated questionnaires.…”

Section: Principal Findingssupporting

confidence: 77%

App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial

Sprave,

Pfaffenlehner,

Stoian

et al. 2023

J Med Internet Res

View full text Add to dashboard Cite

Background Head and neck cancers (HNCs) are very common malignancies, and treatment often requires multimodal approaches, including radiotherapy and chemotherapy. Patients with HNC often display a high symptom burden, both due to the disease itself and the adverse effects of the multimodal therapy. Close telemonitoring of symptoms and quality of life during the course of treatment may help to identify those patients requiring early medical support. Objective The App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer (APCOT) trial aimed to investigate the feasibility of integrating electronic patient-reported outcomes (ePROs) in the treatment surveillance pathway of patients with HNC during the course of their radiotherapy. Additionally, the influence of app-based ePRO monitoring on global and disease-specific quality of life and patient satisfaction with treatment was assessed. Methods Patients undergoing radiotherapy for histologically proven HNCs at the Department of Radiation Oncology, University Medical Center Freiburg, Germany, were enrolled in this trial and monitored by weekly physician appointments. Patients were randomized between additional ePRO monitoring on each treatment day or standard-of-care monitoring. Feasibility of ePRO monitoring was defined as ≥80% of enrolled patients answering ≥80% of their daily app-based questions. Quality of life and patient satisfaction were assessed by the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30), the head and neck cancer module (H&N35), and the validated Patient Satisfaction Questionnaire Short Form (PSQ-18) at the completion of treatment and compared between trial arms. Results A total of 100 patients were enrolled in this trial, and 93 patients were evaluable. All patients (100%) in the experimental arm answered ≥80% of the ePRO questions during treatment, reaching the predefined threshold for the feasibility of ePRO monitoring (P<.001 in the binomial test). No clinical or patient-specific factor was found to influence feasibility. Global health and most domains of the general quality of life were comparable between trial arms, but an increased HNC-specific symptom burden was reported by patients undergoing ePRO surveillance. ePRO monitoring resulted in improved patient satisfaction regarding interpersonal manners (P=.01), financial aspects (P=.01), and time spent with a doctor (P=.01). Conclusions This trial demonstrated the feasibility of incorporating daily app-based ePRO surveillance for patients with HNC undergoing radiotherapy. Our data, for the first time, demonstrate that telemonitoring in this setting led to increased reporting of HNC-specific symptom burden and significantly improved several domains of patient satisfaction. Further analyses are needed to assess whether our findings hold true outside the context of a clinical trial. Trial Registration German Clinical Trials Register DRKS00020491; https://drks.de/search/en/trial/DRKS00020491

show abstract

Section: Principal Findingssupporting

confidence: 77%

App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial

Sprave,

Pfaffenlehner,

Stoian

et al. 2023

J Med Internet Res

View full text Add to dashboard Cite

show abstract

“…By ensuring continuity of care, providers can lead patients to experience better outcomes and higher satisfaction rates, combined with more cost-effective care delivery. PROMs offer the insights needed to aid clinical decision-making and how such decisions affect the ultimate patient outcome [21]. The clinical use of PROMs is essential in the new digital transformation era.…”

Section: Discussionmentioning

confidence: 99%

Perspectives of physicians treating lung cancer patients on the clinical use of outcomes: A qualitative study

Abejas,

Gomes,

Makówka

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Using patient-reported outcome measures (PROMs) in scales can help personalise patient care pathways, including the frequency and type of clinical review (face-to-face visits, phone calls, or video calls). We aimed to elucidate the perception of the outcomes of physicians who treat lung cancer patients and the impact they have on their quality of life through questionnaires, and to establish relationships (related to the patient, the social and family environment, and the diagnosis and treatment), in addition to relating them to multidimensional aspects of the patient’s experience. Additionally, we also identified barriers and facilitators to using the outcome measures. Methods We conducted 16 semi-structured interviews via videoconferencing. The interviews focused on collecting expert opinions on physicians’ perceptions of their patient’s outcomes and the most relevant risk variables. A qualitative thematic analysis was performed. Results Three primary groups were identified in the interview analysis: patient-related, social and family environment, and diagnosis and treatment. No direct relationship was discovered between the perception of outcomes by physicians and experiences of patients and caregivers. Conclusions PROMs need to be implemented in the daily routine of clinical care because physicians generally focus on clinical outcomes rather than patient-centred outcomes, their experiences, and needs. The digitisation of PROMs can facilitate their use. We conclude that barriers and facilitators are a form of methodological division because, in reality, what we perceive as barriers can also be facilitators, depending on several factors, such as health literacy, digital literacy, and socioeconomic level. The use of PROMs is relevant, provided there is feedback, and the outcomes are subsequently managed with the patient. Digitalising PROMs (ePROMs) and videoconferencing or telemedicine could improve these situations. However, this type of digital instrument cannot address some dimensions that measure the need for a different approach, such as spiritual care for end-of-life patients. Thus, physicians can focus their attention on each patient.

show abstract

Patient-reported outcomes in lung cancer surgery: A narrative review

Yi,

Ou-Yang,

Hong

et al. 2024

Asian Journal of Surgery

View full text Add to dashboard Cite

Factors influencing patient satisfaction after treatments for early-stage non-small cell lung cancer

Cited by 8 publications

References 19 publications

App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial

App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial

Perspectives of physicians treating lung cancer patients on the clinical use of outcomes: A qualitative study

Patient-reported outcomes in lung cancer surgery: A narrative review

Contact Info

Product

Resources

About